Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

Details for Australian Patent Application No. 2008214205 (hide)

Owner MAP Pharmaceuticals, Inc.

Inventors Ramadan, Nabih N.; Shrewsbury, Stephen B.; Cook, Robert O.; Armer, Thomas A.

Agent FB Rice

Pub. Number AU-A-2008214205

PCT Pub. Number WO2008/097664

Priority 60/900,850 11.02.07 US

Filing date 11 February 2008

Wipo publication date 14 August 2008

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/097664 Priority application(s): WO2008/097664

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214212-Silane substituted polyethylene oxide reagents and method of using for preventing or reducing aluminosilicate scale in industrial processes

2008214202-Stabilized picoplatin oral dosage form